Evidence map›Paper›PMID 26019207›Full record

ArticleJournal of clinical microbiology2015

Rapid, Sensitive, and Specific Escherichia coli H Antigen Typing by Matrix-Assisted Laser Desorption Ionization-Time of Flight-Based Peptide Mass Fingerprinting.

Huixia Chui, Michael Chan, Drexler Hernandez, Patrick Chong, Stuart McCorrister, Alyssia Robinson, Matthew Walker, Lorea A M Peterson, Sam Ratnam, David J M Haldane and 10 more

Open access · bronzeAbstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 42 citations in OpenAlex.

  1. Analysis of high-molecular-weight proteins using MALDI-TOF MS and machine learning for the differentiation of clinically relevant Clostridioides difficile ribotypes.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  2. Article
  3. Article
  4. ECTyper:Microbial genomics · 2021
    Article
  5. Article
  6. Review
  7. Peptides in Colorectal Cancer: Current State of Knowledge.Plant foods for human nutrition (Dordrecht, Netherlands) · 2020
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 2 countries.

Huixia ChuiNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada Henan Centre of Disease Control and Prevention, Henan Province, China.
Michael ChanNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.
Drexler HernandezNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.
Patrick ChongNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.
Stuart McCorristerNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.
Alyssia RobinsonNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.
Matthew WalkerNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.
Lorea A M PetersonNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.
Sam RatnamNewfoundland and Labrador Public Health Laboratory, St. John's, NL, Canada.
David J M HaldaneNova Scotia Provincial Public Health Laboratory Network, Halifax, NS, Canada.
Sadjia BekalLaboratoire de Santé Publique du Québec, Sainte-Anne-de-Bellevue, Québec, Canada.
John WylieCadham Provincial Laboratory, Winnipeg, MB, Canada.
Linda ChuiProvincial Laboratory for Public Health, University of Alberta Hospital, Edmonton, AB, Canada.
Garrett WestmacottNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.
Bianli XuHenan Centre of Disease Control and Prevention, Henan Province, China.
Mike DrebotNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada Department of Medical Microbiology, College of Medicine, University of Manitoba, Winnipeg, MB, Canada.
Celine NadonNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada Department of Medical Microbiology, College of Medicine, University of Manitoba, Winnipeg, MB, Canada.
J David KnoxNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada Department of Medical Microbiology, College of Medicine, University of Manitoba, Winnipeg, MB, Canada.
Gehua WangNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada Gehua.Wang@phac-aspc.gc.ca Keding.Cheng@phac-aspc.gc.ca.
Keding ChengNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada Department of Human Anatomy and Cell Sciences, College of Medicine, University of Manitoba, Winnipeg, MB, Canada Gehua.Wang@phac-aspc.gc.ca Keding.Cheng@phac-aspc.gc.ca.
Public Health Agency of Canada · CAHenan Provincial Center for Disease Control and Prevention · CNUniversity of Manitoba · CAAlberta Hospital Edmonton · CANova Scotia Health Authority · CASte. Anne's Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has gained popularity in recent years for rapid bacterial identification, mostly at the genus or species level. In this study, a rapid method to identify the Escherichia coli flagellar antigen (H antigen) at the subspecies level was developed using a MALDI-TOF MS platform with high specificity and sensitivity. Flagella were trapped on a filter membrane, and on-filter trypsin digestion was performed. The tryptic digests of each flagellin then were collected and analyzed by MALDI-TOF MS through peptide mass fingerprinting. Sixty-one reference strains containing all 53 H types and 85 clinical strains were tested and compared to serotyping designations. Whole-genome sequencing was used to resolve conflicting results between the two methods. It was found that DHB (2,5-dihydroxybenzoic acid) worked better than CHCA (α-cyano-4-hydroxycinnamic acid) as the matrix for MALDI-TOF MS, with higher confidence during protein identification. After method optimization, reference strains representing all 53 E. coli H types were identified correctly by MALDI-TOF MS. A custom E. coli flagellar/H antigen database was crucial for clearly identifying the E. coli H antigens. Of 85 clinical isolates tested by MALDI-TOF MS-H, 75 identified MS-H types (88.2%) matched results obtained from traditional serotyping. Among 10 isolates where the results of MALDI-TOF MS-H and serotyping did not agree, 60% of H types characterized by whole-genome sequencing agreed with those identified by MALDI-TOF MS-H, compared to only 20% by serotyping. This MALDI-TOF MS-H platform can be used for rapid and cost-effective E. coli H antigen identification, especially during E. coli outbreaks.

Indexed as

Antigens, BacterialBacterial Typing TechniquesEscherichia coliHumansSensitivity and SpecificitySerotypingSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationTime FactorsAntigens, BacterialH antigen

Identifiers

PMID26019207
PMCPMC4508425
OpenAlexW2096989755

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.